G Dailey

Summary

Affiliation: Scripps Clinic
Country: USA

Publications

  1. ncbi request reprint Insulin glulisine provides improved glycemic control in patients with type 2 diabetes
    George Dailey
    Scripps Clinic, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA
    Diabetes Care 27:2363-8. 2004
  2. ncbi request reprint Using prandial insulin to achieve glycemic control in type 2 diabetes
    George E Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA 92037, USA
    J Fam Pract 56:735-42. 2007
  3. doi request reprint Optimum management of type 2 diabetes--timely introduction, optimization and intensification of basal insulin
    G Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, CA 92037, USA
    Diabetes Obes Metab 10:5-13. 2008
  4. doi request reprint Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes
    George Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, California 92037, USA
    Clin Ther 33:665-78. 2011
  5. doi request reprint Overall mortality in diabetes mellitus: where do we stand today?
    George Dailey
    Scripps Clinic Torrey Pines, La Jolla, California 92037, USA
    Diabetes Technol Ther 13:S65-74. 2011
  6. pmc Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir
    George Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA
    Diabetes Technol Ther 12:1019-27. 2010
  7. doi request reprint Reconsideration of severe hypoglycemic events in the treat-to-target trial
    George Dailey
    Scripps Clinic, La Jolla, California 92037, USA
    Diabetes Technol Ther 11:477-9. 2009
  8. doi request reprint Beyond insulin replacement: addressing the additional needs of the diabetes patient
    G Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, CA 92037, USA
    Diabetes Obes Metab 10:83-97. 2008
  9. ncbi request reprint Developing a pulmonary insulin delivery system for patients with diabetes
    George Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 29:1271-83. 2007
  10. ncbi request reprint Developing a pulmonary insulin delivery system for patients with diabetes
    George Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 29:1271-83. 2007

Detail Information

Publications19

  1. ncbi request reprint Insulin glulisine provides improved glycemic control in patients with type 2 diabetes
    George Dailey
    Scripps Clinic, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA
    Diabetes Care 27:2363-8. 2004
    ..Insulin glulisine is a novel analog of human insulin designed for use as a rapid-acting insulin. This study compared the safety and efficacy of glulisine with regular human insulin (RHI) in combination with NPH insulin...
  2. ncbi request reprint Using prandial insulin to achieve glycemic control in type 2 diabetes
    George E Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA 92037, USA
    J Fam Pract 56:735-42. 2007
  3. doi request reprint Optimum management of type 2 diabetes--timely introduction, optimization and intensification of basal insulin
    G Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, CA 92037, USA
    Diabetes Obes Metab 10:5-13. 2008
    ....
  4. doi request reprint Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes
    George Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, California 92037, USA
    Clin Ther 33:665-78. 2011
    ..However, controversy surrounds the ability of such therapy to reduce the risk for macrovascular complications...
  5. doi request reprint Overall mortality in diabetes mellitus: where do we stand today?
    George Dailey
    Scripps Clinic Torrey Pines, La Jolla, California 92037, USA
    Diabetes Technol Ther 13:S65-74. 2011
    ....
  6. pmc Relationship of insulin dose, A1c lowering, and weight in type 2 diabetes: comparing insulin glargine and insulin detemir
    George Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA
    Diabetes Technol Ther 12:1019-27. 2010
    ....
  7. doi request reprint Reconsideration of severe hypoglycemic events in the treat-to-target trial
    George Dailey
    Scripps Clinic, La Jolla, California 92037, USA
    Diabetes Technol Ther 11:477-9. 2009
    ..This article reevaluates the hypoglycemic episodes reported as severe in the Treat-to-Target Trial comparing insulin glargine and NPH insulin use in patients with inadequately controlled type 2 diabetes...
  8. doi request reprint Beyond insulin replacement: addressing the additional needs of the diabetes patient
    G Dailey
    Department of Diabetes and Endocrinology, Scripps Clinic Torrey Pines, San Diego, CA 92037, USA
    Diabetes Obes Metab 10:83-97. 2008
    ..In this review, the clinical properties of these agents and potential treatment pathways to best use these agents are discussed for improving the management of T2DM and cardiovascular risk...
  9. ncbi request reprint Developing a pulmonary insulin delivery system for patients with diabetes
    George Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 29:1271-83. 2007
    ..Inhaled dry powder insulin (IDPI) is approved for preprandial use in both the United States and Europe...
  10. ncbi request reprint Developing a pulmonary insulin delivery system for patients with diabetes
    George Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 29:1271-83. 2007
    ..Inhaled dry powder insulin (IDPI) is approved for preprandial use in both the United States and Europe...
  11. ncbi request reprint Assessing glycemic control with self-monitoring of blood glucose and hemoglobin A(1c) measurements
    George Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic and Research Foundation, 10666 N Torrey Pines Rd, La Jolla, CA 92037, USA
    Mayo Clin Proc 82:229-35; quiz 236. 2007
    ....
  12. ncbi request reprint Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus
    G Dailey
    Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 23:1311-20. 2001
    ..Drug use patterns among patients with type 2 diabetes mellitus have been studied in the general population but not specifically in the Medicaid population...
  13. ncbi request reprint Patient compliance and persistence with anti-hyperglycemic therapy: evaluation of a population of type 2 diabetic patients
    G Dailey
    Scripps Clinic, La Jolla, CA, USA
    J Int Med Res 30:71-9. 2002
    ..Compliance with sulfonylurea or metformin monotherapy was 45% greater than with polytherapy...
  14. ncbi request reprint Improving oral pharmacologic treatment and management of type 2 diabetes
    George E Dailey
    Division of Diabetes and Endocrinology, Scripps Clinic, 10666 North Torrey Pines Rd, La Jolla, CA 92037, USA
    Manag Care 13:41-7. 2004
    ..These measures, along with new oral treatment options, may allow patients and their health care providers to achieve better glycemic control, improve adherence, and reduce the costs associated with this progressive and chronic disease...
  15. ncbi request reprint Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study
    George E Dailey
    Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Clin Ther 24:1426-38. 2002
    ....
  16. ncbi request reprint Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial
    George E Dailey
    Diabetes and Endocrinology, Scripps Clinic, La Jolla, California 92037, USA
    Am J Med 116:223-9. 2004
    ..0% and < or =10.0%)...
  17. ncbi request reprint Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes
    George E Dailey
    Diabetes and Endocrinology, Scripps Clinic, La Jolla, CA 92037, USA
    Expert Opin Pharmacother 4:1417-30. 2003
    ..Glyburide/metformin tablets are an effective option for optimising the control of blood glucose in Type 2 diabetic patients and appear to enhance adherence to therapy...
  18. ncbi request reprint Early insulin: an important therapeutic strategy
    George E Dailey
    Diabetes Care 28:220-1. 2005
  19. ncbi request reprint Gastrointestinal tolerability of extended-release metformin tablets compared to immediate-release metformin tablets: results of a retrospective cohort study
    Lawrence Blonde
    Department of Internal Medicine, Oschner Clinic Foundation, New Orleans, LA, USA
    Curr Med Res Opin 20:565-72. 2004
    ..This retrospective chart review examined the overall gastrointestinal (GI) tolerability of both formulations...